×
For best experience we recommend to activate Javascript in your browser.
NG2 antibody (AA 1705-1942)
The Rabbit Polyclonal anti-NG2 antibody has been validated for WB, IHC and ELISA. It is suitable to detect NG2 in samples from Human.
Quick Overview for NG2 antibody (AA 1705-1942) (ABIN7570242)
Target
See all NG2 (MCSP) Antibodies
NG2 (MCSP)
(Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP))
Reactivity
All reactivities for NG2 antibodies
Human
Host
All hosts for NG2 antibodies
Rabbit
Clonality
All clonalities for NG2 antibodies
Polyclonal
Conjugate
All conjugates for NG2 antibodies
This NG2 antibody is un-conjugated
Application
All applications for NG2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
Product Details anti-NG2 Antibody
(hide)
Binding Specificity
All epitopes for NG2 antibodies
AA 1705-1942
Purpose
Anti-Human CSPG4 Polyclonal Antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human CSPG4 (Ser1705-Ile1942).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for NG2
(hide)
Target
NG2 (MCSP)
(Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP))
Alternative Name
CSPG4
Background
Chondroitin sulfate proteoglycan 4, CSPG4, Chondroitin sulfate proteoglycan NG2, MCSP, Melanoma chondroitin sulfate proteoglycan, Melanoma-associated chondroitin sulfate proteoglycan
UniProt
Q6UVK1
Pathways
Glycosaminoglycan Metabolic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat